Left Atrial Stiffness, a Marker of Atrial Cardiomyopathy, and Atrial Fibrillation – Relationships and Predictors for Procedure Success after Catheter Ablation
Left Atrial Stiffness, a Marker of Atrial Cardiomyopathy, and Atrial Fibrillation – Relationships and Predictors for Procedure Success after Catheter Ablation
WuTC. Left Atrial Stiffness, a Marker of Atrial Cardiomyopathy, and Atrial Fibrillation – Relationships and Predictors for Procedure Success after Catheter Ablation. Arq. Bras. Cardiol. 2019;112(5):509-10.
Wu,Tan Chen. Left Atrial Stiffness, a Marker of Atrial Cardiomyopathy, and Atrial Fibrillation – Relationships and Predictors for Procedure Success after Catheter Ablation. Arq. Bras. Cardiol., v. 112, n. 5, p. 509-510, May. 2019.
Wu,T.C. (2019). Left Atrial Stiffness, a Marker of Atrial Cardiomyopathy, and Atrial Fibrillation – Relationships and Predictors for Procedure Success after Catheter Ablation. Arq. Bras. Cardiol.,112(5), 509-510.
Wu,Tan Chen. Left Atrial Stiffness, a Marker of Atrial Cardiomyopathy, and Atrial Fibrillation – Relationships and Predictors for Procedure Success after Catheter Ablation. Arq. Bras. Cardiol. [online]. 2019, vol. 112, n. 5, [cited 2025-09-06], pp.509-510. Available from: <https://abccardiol.org/en/short-editorial/left-atrial-stiffness-a-marker-of-atrial-cardiomyopathy-and-atrial-fibrillation-relationships-and-predictors-for-procedure-success-after-catheter-ablation/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.
